| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.59B | 37.09B | 34.98B | 35.22B | 34.26B | 32.34B |
| Gross Profit | 4.50B | 4.18B | 3.89B | 3.87B | 3.59B | 3.50B |
| EBITDA | 5.66B | 5.34B | 5.28B | 5.26B | 5.41B | 5.40B |
| Net Income | 1.32B | 1.26B | 1.15B | 1.23B | 1.09B | 915.00M |
Balance Sheet | ||||||
| Total Assets | 41.46B | 43.28B | 41.09B | 36.80B | 35.65B | 35.40B |
| Cash, Cash Equivalents and Short-Term Investments | 6.59B | 7.42B | 6.51B | 6.46B | 4.83B | 4.08B |
| Total Debt | 8.18B | 8.73B | 7.50B | 7.48B | 6.92B | 7.03B |
| Total Liabilities | 15.79B | 17.33B | 16.08B | 14.21B | 14.24B | 14.70B |
| Stockholders Equity | 25.67B | 25.95B | 25.01B | 22.59B | 21.41B | 20.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.62B | 2.44B | 3.62B | 2.38B | 2.62B |
| Operating Cash Flow | 0.00 | 5.11B | 4.98B | 4.71B | 4.67B | 5.06B |
| Investing Cash Flow | 0.00 | -2.61B | -3.13B | -1.05B | -2.25B | -2.42B |
| Financing Cash Flow | 0.00 | -2.60B | -1.82B | -2.05B | -1.67B | -1.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥15.88B | 8.84 | ― | 1.96% | 5.60% | 13.64% | |
73 Outperform | ¥236.11B | 4.69 | 12.70% | 1.68% | 8.29% | 24.94% | |
72 Outperform | ¥7.78B | 7.03 | ― | 0.47% | 3.15% | 4.75% | |
72 Outperform | ¥340.40B | 9.85 | ― | 1.61% | 6.55% | -12.49% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥7.30B | 8.56 | ― | 0.89% | 14.92% | -140.85% | |
59 Neutral | ¥43.26B | 9.60 | ― | 2.58% | 2.36% | -40.95% |